Ponalrestat

CAS No. 72702-95-5

Ponalrestat( ICI 128436 | MK-538 | Ponalrestat )

Catalog No. M15783 CAS No. 72702-95-5

ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 38 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ponalrestat
  • Note
    Research use only, not for human use.
  • Brief Description
    ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice
  • Description
    ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Adult female Sprague-Dawley ratsDosage:10, 50 mg/kg Administration:Orally; daily; 8 weeks Result:Reduced sorbitol accumulation.
  • Synonyms
    ICI 128436 | MK-538 | Ponalrestat
  • Pathway
    Endocrinology/Hormones
  • Target
    Reductase
  • Recptor
    Aldose reductase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    72702-95-5
  • Formula Weight
    391.19
  • Molecular Formula
    C17H12BrFN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(O)CC1=NN(CC2=CC=C(Br)C=C2F)C(C3=C1C=CC=C3)=O
  • Chemical Name
    2-(3-(4-bromo-2-fluorobenzyl)-4-oxo-3,4-dihydrophthalazin-1-yl)acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Pekiner C, McLean WG. Br J Pharmacol. 1990 Dec;101(4):978-80.
molnova catalog
related products
  • beta-Glucogallin

    beta-Glucogallin (beta-Glucogallin) is a selective aldose reductase (AKR1B1) inhibitor with antioxidant, anti-glycation, and anti-inflammatory properties.

  • Zopolrestat

    Zopolrestat is a potent inhibitor of aldose reductase (IC50 = 3.1 nM).

  • ALR2-IN-1

    ALR2-IN-1 is a potent and selective ALR2 inhibitor with an IC50 value of 1.42 μM. ALR2-IN-1 possesses both antiglycemic and antioxidant activities and can be used to study the complications of diabetes.